Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

NCT00258284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: capecitabine
DRUG: docetaxel

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]